Order Article Reprints

Kongsomros S, Suksatu A, Kanjanasirirat P, Manopwisedjaroen S, Prasongtanakij S, Jearawuttanakul K, Borwornpinyo S, Hongeng S, Thitithanyanont A, Chutipongtanate S. Anti-SARS-CoV-2 Activity of Extracellular Vesicle Inhibitors: Screening, Validation, and Combination with Remdesivir. Biomedicines. 2021; 9(9):1230. https://doi.org/10.3390/biomedicines9091230

Kongsomros, Supasek, Ampa Suksatu, Phongthon Kanjanasirirat, Suwimon Manopwisedjaroen, Somsak Prasongtanakij, Kedchin Jearawuttanakul, Suparerk Borwornpinyo, Suradej Hongeng, Arunee Thitithanyanont, and Somchai Chutipongtanate. 2021. "Anti-SARS-CoV-2 Activity of Extracellular Vesicle Inhibitors: Screening, Validation, and Combination with Remdesivir" Biomedicines 9, no. 9: 1230. https://doi.org/10.3390/biomedicines9091230

Kongsomros, S., Suksatu, A., Kanjanasirirat, P., Manopwisedjaroen, S., Prasongtanakij, S., Jearawuttanakul, K., Borwornpinyo, S., Hongeng, S., Thitithanyanont, A., & Chutipongtanate, S. (2021). Anti-SARS-CoV-2 Activity of Extracellular Vesicle Inhibitors: Screening, Validation, and Combination with Remdesivir. Biomedicines, 9(9), 1230. https://doi.org/10.3390/biomedicines9091230